A Randomized Control Trial of Enhanced Cognitive Behavioural Group Therapy for Older Adults with Depression: Efficacy Across Older Age-Groups
Launched by NOVA SCOTIA HEALTH AUTHORITY · Mar 19, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of therapy called Cognitive Behavioural Therapy for Older Adults (CBT-OA), which is designed to help older adults who are feeling depressed. The goal of the study is to see how effective this group therapy is over an 8-week period, where participants will meet for 2 hours each week to learn how to change their thoughts and behaviors to improve their mood. Participants will be randomly assigned to one of two groups: one group will start the CBT-OA treatment right away, while the other group will receive standard care from their doctor for 12 weeks and will be offered the therapy later.
To be eligible for this trial, participants must be at least 65 years old and diagnosed with major depression. They should be able to walk and participate in the therapy. However, those with certain conditions, such as severe mental health issues, dementia, or those currently receiving other intensive treatments, will not be able to join. Throughout the study, both groups will be closely monitored to track their progress. This trial is a great opportunity for older adults dealing with depression to potentially receive effective therapy in a supportive group environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ambulatory patients 65+ years of age and diagnosed with MDE per DSM-V criteria by a geriatric psychiatrist using a standard clinical biopsychosocial assessment and a Beck Depression Inventory (BDI) of \>12.
- Exclusion Criteria:
- • Patients with psychosis, those undergoing acute inpatient care or electroconvulsive therapy (ECT), those with dementia (Mini-Mental Status Examination (MMSE) score of \< 26), and those with chronic personality disorders
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported